收藏切换
Research progress on the prevention and treatment of cerebral ischemia and related diseases by apigenin
收藏切换
PDF
Qian-qian LIU1, 2, Ke WANG3, Yue WANG1, 2, Huai-yu LIU1, 2, Ping LAN1, 2, Shuang ZHANG1, 2, Zhi HE1, 2, 3
Chinese Journal of Clinical Pharmacology | 2025, 41(20) : 2955 - 2961
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(20): 2955-2961
Review
Research progress on the prevention and treatment of cerebral ischemia and related diseases by apigenin
Full
Qian-qian LIU1, 2, Ke WANG3, Yue WANG1, 2, Huai-yu LIU1, 2, Ping LAN1, 2, Shuang ZHANG1, 2, Zhi HE1, 2, 3
Affiliations
  • 1.Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University, Yichang 443002, Hubei Province, China
  • 2.School of Health Medicine, China Three Gorges University, Yichang 443002, Hubei Province, China
  • 3.School of Medicine, Jiaxing University, Jiaxing 314000, Zhejiang Province, China
Published: 2025-10-28 doi: 10.13699/j.cnki.1001-6821.2025.00.018
Outline
收藏切换

Cerebral ischemia is a common neurological disease worldwide, with complex pathophysiological mechanisms, which seriously affects the quality of life of patients after the onset of the disease. Currently, cerebral ischemia is mainly treated with drugs and surgery, and its lethality and disability rate are still at a high level due to the limitation of time window and neurological irreversibility. Therefore, finding a safe and effective drug is crucial for the treatment of cerebral ischaemia. apigenin is a naturally occurring flavonoid with a variety of biological activities, such as combating oxidative stress, anti-inflammatory and neuroprotective effects. In recent years, an increasing number of studies have demonstrated the potential therapeutic role of apigenin in cerebral ischaemia. This paper describes the mechanisms of apigenin in preventing and treating cerebral ischaemia, including anti-oxidative stress, attenuating neuroinflammation, regulating apoptosis and promoting neuroregeneration. In addition, this paper discusses the prospects and challenges for the clinical application of apigenin in the treatment of cerebral ischaemia.

apigenin  /  cerebral ischemia  /  neuroprotection
Qian-qian LIU, Ke WANG, Yue WANG, Huai-yu LIU, Ping LAN, Shuang ZHANG, Zhi HE. Research progress on the prevention and treatment of cerebral ischemia and related diseases by apigenin[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (20) : 2955 -2961 . DOI: 10.13699/j.cnki.1001-6821.2025.00.018
Year 2025 volume 41 Issue 20
PDF
141
30
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.00.018
  • Receive Date:2025-06-13
  • Online Date:2026-08-05
  • Published:2025-10-28
Article Data
Affiliations
History
  • Received:2025-06-13
Funding
Affiliations
    1.Third-grade Pharmacological Laboratory on Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, China Three Gorges University, Yichang 443002, Hubei Province, China
    2.School of Health Medicine, China Three Gorges University, Yichang 443002, Hubei Province, China
    3.School of Medicine, Jiaxing University, Jiaxing 314000, Zhejiang Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.00.018
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT